Chemical and Pharmaceutical Bulletin p. 1532 - 1537 (1999)
Update date:2022-07-31
Topics:
Akasaka, Kozo
Komatsu, Yuki
Tagami, Katsuya
Shimizu, Toshikazu
Shimomura, Naoyuki
Naka, Hiroshi
Hayashi, Kenji
Negi, Shigeto
An efficient synthetic process for the key intermediate of a new peptidomimetic dual metalloprotease inhibitor, ER-40133, was developed. (5R)- Methyl-6-oxopipecolic acid ester (3a), prepared from L-α,-aminoadipic acid, was chemoselectively reduced to the
View MoreHangzhou Hysen Pharma co.,Ltd.
website:http://www.hysenpharma.cn/
Contact:0086-571-88298791
Address:#701,Gudun Road Hangzhou
Taizhou Elitechemie MediPharma Technology Co.,Ltd.
Contact:+86-523-86810021
Address:Building G14,NO.1 Avenue,China Medical City, Taizhou, Jiangsu,China
Rizhao Lanxing Chemical Indusrial Co.,Ltd
Contact:86-633-2616708
Address:NO.15 West road Shenglan, Lanshan district, Rizhao City
Contact:+86-717-6370352
Address:168 Chengdong Avenue, Yichang, Hubei 443003, P. R.China
Jinan Jianfeng Chemical Co., Ltd
Contact:0086-531-88110457
Address:sales01(-a-t-)pharmachemm{dot}c+o+m
Doi:10.1016/j.molstruc.2012.12.018
(2013)Doi:10.3109/14756366.2011.653355
(2013)Doi:10.1039/c3ra41640b
(2013)Doi:10.1021/ol400493x
(2013)Doi:10.1016/j.jorganchem.2013.01.013
(2013)Doi:10.1021/om400025h
(2013)
